Dose daily

Seven Clinical Trial Ethics Panels Lose CDSCO Registration in Compliance Crackdown

The Central Drugs Standard Control Organisation (CDSCO) has withdrawn registration certificates from seven Ethics Committees nationwide after risk-based audits uncovered serious lapses under the New Drugs and Clinical Trials...

From Research to Revolution: Novo Nordisk Shares Oral GLP-1 Breakthrough Story

Novo Nordisk has shared the scientific journey behind turning an injectable biologic medicine into a pill — a...

Biozenta Lifescience to Build ₹1,250 Crore Oncology Plant in Barabanki, UP

Biozenta Lifescience Pvt. Ltd., a global leader in oncology medicines, has announced plans to establish a state-of-the-art manufacturing facility in Barabanki, Uttar...

​Zydus Collaborates with ICMR to Address Sickle Cell Disease as Desidustat Enters Phase III

Zydus Lifesciences Limited, in collaboration with the Indian Council of Medical Research (ICMR), has announced the successful completion of...

VELMENI Secures FDA Nod for Advanced AI-Driven 3D Dental Imaging

Sunnyvale, California-based dental AI firm VELMENI announced on July 23, 2026, that the U.S. FDA has granted 510(k)...

MSPC Launches ₹5 Lakh Support Scheme for Maharashtra Pharmacists

The Maharashtra State Pharmacy Council (MSPC) has introduced the Pharmacist Suraksha Kavach Yojna, a welfare scheme offering ₹5 lakh financial support to the family of...

West Bengal’s CM Suvendu Adhikari Launches Free Statewide Cervical Cancer Shield for 7.5 Lakh Girls

In a major boost to women's healthcare in the state, West Bengal Chief Minister Suvendu Adhikari on Saturday officially launched a massive, statewide Human Papillomavirus (HPV) vaccination campaign. The...

AbbVie’s DECNUPAZ™ got Approval from FDA: First and Only Antibody-Drug Conjugate (ADC) Treatment

AbbVie (NYSE: ABBV) announced that the U.S. Food and Drug Administration (FDA) has approved DECNUPAZTM (pivekimab sunirine-pvzy), first and only antibody-drug conjugate (ADC) drug for the treatment of Blastic Plasmacytoid Dendritic Cell...

Lupin’s Ankleshwar Plant Secures US FDA EIR

Global pharma major Lupin Limited (Lupin)  announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA)...

Wockhardt Achieves Milestone Approval for First-in-Class Antibiotic ZAYNICH®️

Wockhardt Ltd., a research-based global pharmaceutical and biotechnology company, announced that the Central Drugs Standard Control Organisation (CDSCO) has granted marketing authorization for the import...

Anupam Rasayan is Preparing to Acquire 43% Stake in Bliss GVS Pharma for Around ₹1,369 Crore

Anupam Rasayan India the Gujarat based Specialty chemicals maker is all set to acquire 43.3 % stake in pharmaceutical formulations company Bliss GVS Pharma Ltd. According to reports Anupam Rasayan has already signed an agreement...